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Summary
T-cell immunoglobulin and mucin (TIM) family molecules are cell mem-
brane proteins, preferentially expressed on various immune cells and
implicated in recognition and clearance of apoptotic cells. Little is known
of their function outside human and mouse, and nothing outside mam-
mals. We identified only two TIM genes (chTIM) in the chicken genome,
putative orthologues of mammalian TIM1 and TIM4, and cloned the
respective cDNAs. Like mammalian TIM1, chTIM1 expression was
restricted to lymphoid tissues and immune cells. The gene chTIM4
encodes at least five splice variants with distinct expression profiles that
also varied between strains of chicken. Expression of chTIM4 was detected
in myeloid antigen-presenting cells, and in cd T cells, whereas mammalian
TIM4 is not expressed in T cells. Like the mammalian proteins, chTIM1
and chTIM4 fusion proteins bind to phosphatidylserine, and are thereby
implicated in recognition of apoptotic cells. The chTIM4–immunoglobulin
fusion protein also had co-stimulatory activity on chicken T cells,
suggesting a function in antigen presentation.
Keywords: chicken; comparative immunology; TIM1; TIM4.
Introduction
The T-cell/transmembrane, immunoglobulin and mucin
(TIM) family are cell surface receptors that recognize
phosphatidylserine but also regulate both innate and
adaptive immune responses.1 In both mouse and human,
the TIM family has multiple members (eight in mouse
and three in human). Research has focused on the family
members that are conserved between human and
mouse – TIM1–4 in mouse (TIM5–8 are to date pre-
dicted genes only) and the three human TIM molecules
(TIM1, TIM3 and TIM4). TIM2 is absent in human,
although human TIM1 shares 32–42% amino acid iden-
tity with mouse TIM1 and TIM2 respectively and may
fulfil the functions of both.
In mice, TIM1 was preferentially expressed on T helper
type 2 (Th2) cells and reciprocally regulates Th2
responses, which have been demonstrated by different
groups using agonistic/antagonistic anti-TIM1 mono-
clonal antibodies (mAbs).2–4 TIM3 was preferentially
expressed on Th1 cells; once engaged, it negatively regu-
lated Th1 immunity.5,6 TIM3 was also expressed on den-
dritic cells, where it mediated phagocytosis of apoptotic
cells and contributed to antigen cross-presentation.7
TIM4 was also suggested to be expressed exclusively on
antigen-presenting cells (APC), where it contributed to
phagocytosis of apoptotic cells and maintenance of toler-
ance.8,9 TIM4 also bilaterally regulates T-cell responses by
promoting activated T-cell survival and expansion10,11 but
suppressing naive T-cell proliferation.12
Abbreviations: aa, amino acids; BM-APC, bone marrow-derived antigen-presenting cells; BM-Mф, bone marrow-derive macro-
phage; chTIM, chicken TIM; ConA, concanavalin A; Ct, cycle threshold value; DMEM, Dulbecco’s modified Eagle’s medium;
EST, expressed sequence tag; FCS, fetal calf serum; GM-CSF, granulocyte–macrophage colony-stimulating factor; Ig domain,
mucin domain; IgFc, immunoglobulin Fc domain; IgV, immunoglobulin variable domain; IL-4, interleukin-4; mAb, monoclonal
antibody; nt, nucleotides; PC, L-a-phosphatidylcholine; PE, 3-sn-phosphatidylethanolamine; PI, L-a-phosphatidylinositol; PS,
3-sn-phosphatidyl-L-serine; SPF, specific pathogen-free; Th2, T helper type 2; TIM, T cell/transmembrane, immunoglobulin and
mucin
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The chicken is the non-mammalian species in which
the immune response is best characterized. The chicken
response to pathogen challenge is broadly similar to that
of mammals, in that it is capable of mounting innate
immune responses that drive both inflammatory (cell-
mediated) and humoral immune responses and resultant
memory. Chickens share with mammals the Th1/Th2
polarization of T-cell cytokine profiles. The response to
intracellular pathogens is dominated by interferon-c and
that to extracellular pathogens by interleukin-4 (IL-4)
and IL-13.13–15 This is compelling evidence for the polar-
ization of type 1 and type 2 adaptive immune responses
extending beyond mammalian species to at least galliform
birds. It remains to be determined whether this paradigm
holds at the cellular and molecular levels and whether
avian T helper cells can become terminally polarized to a
Th1 or Th2 phenotype.
Despite the similarities, the immune organs, cells and
molecules used by the chicken to mount innate and adap-
tive responses can differ from those in mammals. Birds
lack lymph nodes, and macrophages (expressing the CSF1
receptor) appear to take the role of antigen-trapping cells
within B-cell areas, the role of non-haematopoietic follic-
ular dendritic cells in mammals.16 Only recently has the
existence of a classical Flt3-positive ‘dendritic cell’ been
inferred in the chicken,17 but the relative importance in
immune responses is not clear. In particular, chicken
Th2-driven responses seem to be different to those of
mammals. Chickens lack IgE and subclasses of IgY (the
avian homologue of IgG); functional eosinophils appear
to be absent; the eotaxins and the eotaxin receptor are
absent;18 IL-5 mRNA expression is switched off during
Th2 responses15 and Th2-associated allergies have not
been described for birds.
As Th1/Th2 polarization is apparently shared to a
degree between birds and mammals, as is the clearance of
dying cells by phagocytes,16 we aimed to identify the
repertoire and biological function of the TIM family of
molecules in the chicken.
Materials and methods
Chicken tissues and cells
Chicken line 72 was bred and maintained under specific
pathogen-free (SPF) conditions at the Institute for Ani-
mal Health. J line was intercross-bred from nine lines,
originally inbred from Brown Leghorn chickens at the
Poultry Research Centre, Edinburgh, and conventionally
raised at The Roslin Institute. Line72 was bred by trait of
resistance to pathogens19 and J line to study a variety of
traits, such as egg laying, plumage and vigour (http://
www.narf.ac.uk/chickens/lines). These two lines were cho-
sen for this study because of their clear genetic back-
ground and diversity of breeding and in the hope of
finding out whether genetic diversity has any effect on
chicken TIM family molecules. Tissues were removed
from 6-week-old chickens, either line 72, or J line, with-
out or with standard vaccine immunizations respectively,
specifically thymus, spleen, bursa of Fabricius, Harderian
gland, caecal tonsil, Meckel’s diverticulum, bone marrow,
brain, muscle, heart, liver, kidney, lung, skin, small intes-
tine and testis. Lymphocyte subsets (CD3+, CD4+,
CD8a+, CD8b+, TCRab +, TCRcd+, Bu-1+) and KUL01+
myeloid cells were isolated from total splenocytes pooled
from three birds, as previously described.20 Bone mar-
row-derived APC [BM-APC, grown in granulocyte–
macrophage colony-stimulating factor (GM-CSF)/IL-4]
and macrophages (BM-MФ, grown in CSF1) were iso-
lated from two femurs from one bird and peripheral
blood monocyte-derived macrophages were isolated from
a pooled blood sample from three birds of 4- to 8-week-
old line 72 or J line chickens; as described previously,
20–22
and stimulated with lipopolysaccharide (Sigma-Aldrich,
Dorset, UK) or recombinant chicken CD40 ligand
(rchCD40L) for 24 hr. BM-APC are preferred to bone
marrow-derived dendritic cells, as used previously,
because it is unclear whether classical Flt3-dependent
dendritic cells are present in birds and despite their APC
activity, the phenotype of the BM-APC is primarily
macrophage-like.
Cloning and sequencing of cDNA
Total RNA (5 lg), extracted from the spleen of a 6-week-
old line 72 bird, was reverse-transcribed into cDNA using a
Superscript II kit (Invitrogen, Paisley, UK) to use as a tem-
plate to amplify the chTIM1 cDNA by PCR; sequence-spe-
cific primers TIM1-F1/R1 (see Table 1) and 0625 U
GoTaq DNA polymerase (Promega, Southampton, UK)
were used in a 20-ll total volume with the PCR as follows:
after denaturation of the cDNA template at 94° for 3 min,
a touch-up PCR was carried out with cycling conditions of
94° for 1 min, 50° for 30 seconds and 72° for 90 seconds
for three cycles; 94° for 1 min, 52° for 30 seconds and 72°
for 90 seconds for three cycles; 94° for 1 min, 54° for
30 seconds and 72° for 90 seconds for 30 cycles. The first-
round PCR product was then used as template for amplifi-
cation with a nested primer pair, TIM1-F2/R2. Cycling
conditions were 94° for 3 min, followed by 34 cycles of 94°
for 1 min, 50° for 30 seconds and 72° for 2 min.
For amplification of chTIM4 cDNA, bone marrow was
isolated from a 6-week-old J line bird and cells were puri-
fied as previously described;21 total RNA (2 lg), extracted
from the cells, was reverse-transcribed into cDNA as
before. The chTIM4 cDNA was amplified, using
sequence-specific primer pair TIM4-F1/R1 with a touch-
down PCR with cycling conditions of 94° for 3 min; 94°
for 1 min, 60° for 30 seconds and 72° for 2 min for three
cycles; 94° for 1 min, 58° for 30 seconds and 72° for
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2 min for three cycles; 94° for 1 min, 57° for 30 seconds
and 72° for 2 min for 30 cycles. Again the first-round
PCR product was used as template for amplification with
a nested primer pair, TIM4-F2/R2. Cycling conditions
were 94° for 3 min; 94° for 1 min, 60° for 30 seconds
and 72° for 25 min for three cycles; 94° for 1 min, 61°
for 30 seconds and 72° for 25 min for 30 cycles.
The cDNAs were initially cloned into pGEM-T Easy
(Promega) and sequence verified. The complete amplified
cDNA sequences of both genes were submitted to the
EMBL Nucleotide Sequence Database with accession num-
bers of HG425163 for chTIM1, LN831082 for chTIM4L0,
HG425165 for chTIM4L1, LN831081 for chTIM4L2,
HG425164 for chTIM4 and LN831080 for chTIM4S.
Real-time quantitative RT-PCR analysis of chTIM
family member expression
RNA from the tissues and cells described above was
extracted using an RNeasy Mini kit (Qiagen, Manchester,
UK) following the manufacturer’s instructions. TaqMan
real-time quantitative RT-PCR was used to quantify the
mRNA levels of the chTIM family members. Primers and
probes specific to the different chTIM family members
(Table 2) were designed using PRIMER EXPRESS (Applied Bio-
systems, Paisley, UK). Assays were performed using the Taq-
Man Fast Universal PCR master mix and one-step RT-PCR
master mix reagents (Applied Biosystems). Data are
expressed in terms of the cycle threshold value (Ct), normal-
ized for each sample using the Ct value of 28S rRNA product
for the same sample, as described previously.14,15,23
Expression of recombinant proteins in COS-7 cells
The different domains of chTIM1 and chTIM4 were
amplified using the primer pairs shown in Table 1 and
subcloned into expression vectors for expression as IgFc-
fusion proteins. For chTIM1, the IgV domain (amino
acids 1–130) and the full extracellular domain (amino
acids 1–207) were subcloned into the vector pKW06-Ig.24
The mucin domain (amino acids 131–207) was subcloned
into the vector BR-Ig.25 For the chTIM4 isoforms, the
IgV domains (amino acids 1–130 for chTIM4, 1–316 for
chTIM4L1) and the full extracellular domains (amino
acids 1–299 for chTIM4, 1–497 for chTIM4L1) were sub-
cloned into pKW06. The mucin domain (amino acids
131–299 from chTIM4) was subcloned into BR-Ig. All of
the recombinant plasmids were sequence-verified.
The different chTIM IgFc fusion proteins were
expressed in COS-7 cells using a well-described DEAE-
dextran transfection method.26,27 Successful expression
was confirmed with a sandwich ELISA using unlabelled
and horseradish peroxidase-labelled goat anti-human IgG
(SouthernBiotech, Cambridge, UK) as capture and detec-
tion reagents,24 and the relative protein concentration
estimated by comparison with a human IgFc protein
standard (R&D Systems, Abingdon, UK).
The above transfection procedure was repeated several
times to yield large volumes of supernatant for each
recombinant TIM IgFc protein. The fusion proteins were
purified on protein G columns (GE Healthcare, Amer-
sham, UK) following the manufacturer’s instructions.
Characterization of chTIM family molecule ligands on
chicken splenocytes
To characterize the potential ligands for the chTIM family
molecules, freshly isolated chicken splenocytes were
incubated for 1 hr on ice with COS-7 cell supernatants
Table 1. Primers use to amplify chicken T-cell immunoglobulin and
mucin (chTIM) family cDNAs and to generate expression constructs
Primer Sequence (5’–3’)
TIM1-F1 AATAAGAGTGTTCCTCATC
TIM1-R1 AAGTTTTTAATTAGAATTGTAGC
TIM1-F2 ATGTCTTCTCATTTCTTCC
TIM1-R2 TTAATTAGAATTGTAGCTTTTATTTG
TIM4-F1 AGCCAAAATGTCCCACTTT
TIM4-R1 ACACAGATCCCAGAAATACTACTG
TIM4-F2 ATGTCCCACTTTGTGTTGTTTC
TIM4-R2 TCACAGCACAAAAAGGTTGT
TIM1-IgVF GCTAGCATGTCTTCTCATTTCTTC
TIM1-IgVR AGATCTTCAACCACCACCTGGAGGTT
TIM1-mucinF GCTAGCAGAGCTAGGGTCTCTACT
TIM1-mucinR AGATCTTTTTCTGAATACTGCTGACT
TIM4S-IgVF GCTAGCATGTCCCACTTTGTGTT
TIM4S-IgVR AGATCTAGCACCACCAGCTGAATGTT
TIM4S-mucinF GCTAGCGAAGCACCTCCATTGATG
TIM4S-mucinR AGATCTGGAAAGGAAAGTTTCATCCC
Nucleotides in bold italics show the NheI or BglII restriction enzyme
sites introduced to facilitate directional cloning into the vectors
pKW06-Ig and BR-Ig.
Table 2. Real-time quantitative RT-PCR probes and primers
RNA target Probe/primer sequence (5’–3’)
Exon
boundary
28S Probe (FAM)-AGGACCGCTACG
GACCTCCACCA-(TAMRA)
F GGCGAAGCCAGAGGAAACT
R GACGACCGATTTGCACGTC
chTIM1 Probe (FAM)-TGGCTTACAGGCC
CCACAGTGTCG-(TAMRA)
1/2/3
F TCCTGGACTGGATCCTTCTGA
R TCTGACCAACCTCTCCCTTCA
chTIM4
isoforms
Probe (FAM)-ACTGTAGCAACAGC
ACTGCCAGAGCCA-(TAMRA)
7/8
F AGTTCTCTCTTGGCAGATGATGTG
R AAGGGTTAACTTCGGTGTCTGAAG
F, forward primer; R, reverse primer.
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containing the recombinant IgV-, mucin- and full extra-
cellular-domain chTIM1 or chTIM4 IgFc fusion proteins,
with human IgFc protein (R&D Systems) as a control.
The chTIM1 fusion proteins were adjusted to 5 lg/ml
with Dulbecco’s modified Eagle’s medium (DMEM) plus
10% fetal calf serum (FCS), and the chTIM4 fusion pro-
teins to 3 lg/ml. After two washes, the cells were stained
with an FITC-conjugated goat anti-human IgG mAb
(Southern Biotech) for 1 hr on ice. The staining results
were analysed by flow cytometry on a FACSCalibur
instrument (BD Biosciences, Oxford, UK). To determine
whether activation affects expression of the chTIM4
ligands, splenocytes were co-cultured without or with
2 lg/ml of rchCD40L or 2 lg/ml concanavalin A (ConA;
Sigma-Aldrich) for 48 hr. The cells were then double-
stained with chTIM4-extracellular domain immunoglobu-
lin or an immunoglobulin control (R&D Systems) fusion
protein, labelled with Alexa Fluor-647 using a Zenon
labelling kit (Invitrogen), and CD3-FITC or Bu-1-FITC
mAbs (Southern Biotech).
Binding of TIM proteins to phospholipids
L-a-phosphatidylcholine (PC) from egg yolk, 3-sn-phos-
phatidylethanolamine (PE) from bovine brain, L-a-phos-
phatidylinositol (PI) ammonium salt solution from
bovine liver and 3-sn-phosphatidyl-L-serine (PS) sodium
salt from bovine brain (all from Sigma-Aldrich) were dis-
solved in chloroform. The interactions between the
chTIM proteins and these phospholipids were tested by a
phospholipid binding assay on nitrocellulose membrane
and a solid-phase ELISA as previously described.8 To
determine whether pre-incubation of chTIM4 IgFc fusion
proteins with PS blocks binding, splenocytes were co-cul-
tured without or with 2 lg/ml rchCD40L or 2 lg/ml
ConA for 48 hr. PS was diluted in PBS and sonicated in
an ultrasonic liquid processor (Misonix, Farmingdale,
NY) at full power for 5 min to yield a 15 M solution.
The chTIM4-extracellular-domain IgFc fusion protein, or
recombinant chCTLA4-extracellular-domain IgFc fusion
protein as a negative control, was diluted in DMEM plus
10% FCS, 25 mM CaCl2, with PS added at 50 nmol
(012 lg) per lg protein and incubated for 1 hr at room
temperature. The blocked and unblocked recombinant
proteins were diluted to 10 lg/ml in DMEM plus 10%
FCS, 25 mM CaCl2. This solution was used to immunos-
tain the above cultured splenocytes, followed by an FITC-
conjugated rabbit anti-human IgG polyclonal antibody
(Southern Biotech), and the results were analysed by flow
cytometry.
Co-stimulation of splenocytes
Anti-chicken CD3 and CD28 mAbs (Southern Bio-
tech) were pre-coated on a flat-bottomed 96-well
tissue culture plate, adding 50 ll of either antibody at
10 lg/ml in sterile PBS, for 3 hr at 37°. The plates
were then vigorously washed three times with sterile
PBS. Isolated chicken splenocytes, 20 9 105 cells/well
in 100 ll medium, were cultured in this plate without
or with recombinant chTIM4-Ig protein, at different
concentrations. After 48 hr of growth at 41° in 5%
CO2, the cells were pulsed with 1 lCi of [
3H]thymi-
dine per well for 16 hr. Incorporation of [3H]thymi-
dine (corrected counts per minute) was measured in
a scintillation b-counter (Perkin Elmer, Waltham,
MA).
Monoclonal antibody generation and characterization
Fusion proteins for immunization were expressed from
cloned, transfected Chinese hamster ovary cells,
selected by ELISA for high-level expression as
described before25 and purified on protein G columns
(GE Healthcare). Two Biozzi strain mice were immu-
nized with the chTIM4L1-linker-domain (amino acids
131–207) IgFc fusion protein and three BALB/c strain
mice with the chTIM4-extracellular-domain (amino
acids 1–209) IgFc fusion protein. All mice were immu-
nized three times with a subcutaneous injection of the
immunoglobulin fusion proteins emulsified with Titer-
Max Gold (Invitrogen) as adjuvant. A final boost was
an intraperitoneal injection of the immunoglobulin
fusion proteins without adjuvant. Spleen cells were
fused with Sp2/0-Ag14 mouse myeloma cells28 accord-
ing to standard procedures.29
The specificity of anti-chTIM4 mAbs was examined by
immunostaining of COS-7 cells using anti-chTIM4 mAbs,
JH9 (anti-chTIM4) and IE12 (anti-chTIM4L1-linker), in
which the COS-7 cells were transiently transfected with
plasmids encoding full-length cDNAs for chTIM4 and
chTIM4L1, or empty plasmid (mock), using Lipofectine
2000 (Life Technologies, Paisley, UK) and grown for
48 hr at 37°, 5% CO2. The cell lysates of similarly trans-
fected COS-7 cells were resolved on 4–12% SDS–PAGE
gels (Bio-Rad, Hemel Hampstead, UK) for Western blot
analysis and the chTIM4 proteins were probed by JH9
and IE12 mAbs.
Expression of chTIM4 on chicken antigen-presenting cells
The BM-APC, BM-MФ and bursal cells (predominantly B
cells) were immunostained with the anti-chTIM4 mAbs
(JH9 or IE12) or isotype-matched controls. The sec-
ondary antibody was Alexa Fluor 647-conjugated goat
anti-mouse IgG (Southern Biotech). Cells were analysed
by flow cytometry using a FACSCalibur instrument (BD
Biosciences) and the resulting data were analysed with
FLOWJO software.
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Results
The chTIM family has only two members, but
chTIM4, unlike mammalian TIM4, has several
isoforms
The amino acid sequences of human TIM1, TIM3 and
TIM4 were used as probes in BLAST searches against the
chicken expressed sequence tag (EST) and genome data-
bases (v.38) in ENSEMBL. The resulting EST hits
matched two clusters of overlapping chicken EST
sequences, which were homologous to human TIM1 and
TIM4, respectively. The chTIM family was identified on
chromosome 13 by examining conserved synteny between
the human and mouse TIM family clusters on chromo-
somes 5 and 11, respectively, and the chicken genome
(Fig. 1). Only two genes were identified in the chicken.
Other avian genomes were then compared; again, two
genes (TIM1 and TIM4) were identified in the turkey,
but three (TIM1, TIM3 and TIM4) were identified in the
zebra finch (Fig. 1).
A cDNA for TIM1 was amplified from spleen RNA.
The chTIM1 cDNA consists of 828 nucleotides (nt),
encoding an open reading frame of 275 amino acids (aa),
with the predicted signal sequence (SIGNALP 3.0) compris-
ing the first 21 aa. Comparison of the predicted amino
acid sequence of chTIM1 with human and mouse TIM1
(Fig. 2) revealed 32–33% amino acid identity. Overall the
secondary structure of TIM1 appears conserved, with an
apparent extracellular IgV domain with six conserved cys-
teine residues and a PS-binding site (WFND),9,30 a less
structured extracellular mucin domain, a hydrophobic
transmembrane domain and an intracellular domain con-
taining a tyrosine kinase phosphorylation site (AED/E-
NIY).31,32
Amplification of cDNA for TIM4 yielded multiple
products (Fig. 3a). All were cloned, sequenced and
shown to be isoforms homologous to mammalian
ITK Fam71b Med7
Tim3 Tim1 Tim4
SGCDPPPR2P3
ITK Fam71b Med7
GM12171
Tim3
Tim3
Tim5
GM12171
Rpl9ps2
Tim6 Tim8 Tim7 Tim2
GM12174
Tim1 Tim4
SGCD
Mouse Chr. 11
Human Chr. 15
Chicken Chr. 13
ITK Med7
Tim1 Tim4
Tim1 Tim4
SGCD
ITK Med7 SGCD
Turkey Chr. 15
Tim1 Tim4
ITK Med7 SGCD
Zebra finch Chr. 13
Figure 1. Schematic depicting the T-cell immunoglobulin and mucin (TIM) gene family locus with a degree of conserved synteny between mammals
(human and mouse) and birds (chicken, turkey and zebra finch). Human has three family members, the mouse eight, but four of these (shown in ital-
ics) are apparently pseudogenes. In contrast, the chicken and turkey both have only two members, whereas the zebra finch has three.
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       signal peptide → ♦ IgV →
moTim1 MNQIQVFISGLILLLPGAVDSYVEVKGVVGHPVTLPCTYSTY--RGITTT  48 
huTim1 -MHPQVVILSLILHLADSVAGSVKVGGEAGPSVTLPCHYS----GAVTSM  45 
chTim1 MSSHFFLDWILLIWLTGPTVSGLLVKGEVGQNVTVPCFYRVKTEYDITSM  50 
moTim1 CWGRGQCPSSACQNTLIWTNGHRVTYQKSSRYNLKGHISEGDVSLTIENS  98 
h Ti 1 CWNRGSCSLFTCQNGIVWTNGTHVTYRKDTRYKLLGDLSRRDVSLTIENT 95u m
chTim1 CWGRDACPASKCSQPIIWTDGRKVTERHHTKYVLKGDLLKGNVSLTILNA 100 
♦ mucin →
moTim1 VESDSGLYCCRVEIPGWFNDQKVTFSLQVKP----------EIPTRPPRR 138 
huTim1 AVSDSGVYCCRVEHRGWFNDMKITVSLEIVPPKVTTTPIVTTVPTVTTVR 145 
chTim1 QETDSGTYCCRVEIPGWFNDETTNLQVVVER------------ARVSTAS 138 
∆∆∆∆
moTim1 ----------------PTTTRPTATGRPT--------TISTRS------- 157 
huTim1 TSTTVPTTTTVPMTTVPTTTVPTTMSIPTTTTVLTTMTVSTTTSVPTTTS 195 
chTim1 ----------------PLTHTSPPTSAPG--------------------- 151 
moTim1 ----THVPTSTRVSTSTP-------------------------------- 171
huTim1 IPTTTSVPVTTTVSTFVPPMPLPRQNHEPVATSPSSPQPAETHPTTLQGA 245 
chTim1 ----SASEESFTVSTWPP-------------------------------- 165 
♦
moTim1 ----PTSTHTWTHKPDWNGTVTSSGD-TWSNHTEAIPPGK--PQKNPTKG 214 
huTim1 IRREPTSSPLYSYTTDGNDTVTESSDGLWNNNQTQLFLEHSLLTANTTKG 295 
chTim1 -----VSVSEAPETASGPYSSTSDYPEVTSSLQNSSISTHSQQYSEKTVY 210
       transmembrane → ♦ intracellular →
moTim1 FYVGICIAALLLLLLVSTVAITRYILMKRKSASLSVVAFRVSKIEALQNA 264 
huTim1 IYAGVCISVLVLLALLG-VIIAKKYFFKKEVQQLS-VSFSSLQIKALQNA 343 
chTim1 LRTGLCVAFLVILVVGLFLGRRYLRNMKKLSKFASSVAFWRTERAGNQSA 260 
moTim1 AVVHSRAEDNIYIVEDRP--- 282 
huTim1 VEKEVQAEDNIYIENSLYATD 364 
chTim1 LEVEIHAEENIYTIH------ 275 
              *****              
Figure 2. Alignment of the predicted chicken T-cell immunoglobulin and mucin 1 (chTIM1) amino acid (aa) sequence with those of human and
mouse TIM1, with reference to secondary structural features and functionally important residues. Shaded areas represent conservation of amino
acid similarity – the darker the shading, the more conserved the residue across species. Dashes indicate gaps in the alignment. Filled triangles
indicate the conserved six cysteines and empty triangles the conserved phosphatidylserine-binding site (WFND). Asterisks depict the conserved
tyrosine kinase phosphorylation site (AED/ENIY). Potential N-linked glycosylation sites in the chicken molecule are highlighted by solid dots.
Filled diamonds above the sequences label the start-points of each domain. The accession numbers of the sequences used are as follows: mouse,
AAL35775; human, NP036338; chicken, HG425163.
Figure 3. Identification and characterization of chicken T-cell immunoglobulin and mucin 4 (chTIM4) isoforms. (a) Amplification of four iso-
forms of chTIM4 from bone marrow cells from a 6-week-old J line bird. (b) Alignment of the predicted chTIM4 amino acid (aa) sequence with
those of human and mouse TIM4, with reference to secondary structural features and functionally important residues. Shaded areas represent
conservation of amino acid similarity – the darker the shading, the more conserved the residue across species. Dashes indicate gaps in the align-
ment. Filled triangles indicate the six conserved cysteines and empty triangles the conserved phosphatidylserine binding site (WFND). Potential
N-linked glycosylation sites in the chicken molecule are highlighted by solid dots. Filled diamonds above the sequences label the start-points of
each domain. The accession numbers of the sequences used are as follows: mouse, NP848874; human, NP001140198; chicken, HG425164. (c)
Structure of the chTIM4 gene showing the different exons used to encode chTIM4L0, chTIM4L1, chTIM4L2, chTIM4 and chTIM4S. The open
reading frame (ORF) encoding chTIM4L0 consists of exons 1–12; exon 2 encodes an IgV domain, exon 5 a second IgV domain, and exons 3, 4
and part of exon 5 a linker between the two IgV domains. The ORF encoding chTIM4L0 is similar to that encoding chTIM4L1 but has an
extended exon 3. By contrast, chTIM4L2 lacks the whole exon 3, chTIM4 lacks exons 3, 4 and 5, being encoded by nine exons and chTIM4S lacks
exons 5–8, being encoded by eight exons. The number above each exon shows its length in aa, and that below its number.
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chTim4  ISDMCWGRGPCPNSKCNGKLLHTTGNRVTFRTSQRYNLQGYISYGDVSL  95
 mucin 
moTim4   TISNTNRGDSGVYCCRIEVPGWFNDVKKNVRLELRRATTT--KKPTTTT 144
huTim4   TILNPSESDSGVYCCRIEVPGWFNDVKINVRLNLQRASTTTHRTATTTT 146
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TIM4; one isoform was of a similar length to mam-
malian TIM4, named as chTIM4. Alternative forms
were either shorter [chTIM4S (short)] or longer
[chTIM4L (long)]. The chTIM4L displayed additional
heterogeneity, based on the length of exon 3; they were
further named as chTIM4L0 (with the longest exon 3),
chTIM4L1 (with a shorter exon 3) and chTIM4L2 (lack-
ing exon 3).
The dominant chTIM4 amplicon consists of 1363 nt,
encoding an open reading frame of 359 aa, with the pre-
dicted signal sequence (SIGNALP 3.0) comprising the first
21 aa. Comparison of the predicted amino acid sequence
of chTIM4 with human and mouse TIM4 (Fig. 3b)
revealed 28–32% amino acid identity. As with TIM1, the
secondary structure of chTIM4 is predicted to be similar
to the mammalian proteins, with an extracellular IgV
domain with six conserved cysteine residues and a con-
served PS binding site (WFND),8,9,30 a less structured
extracellular mucin domain, a hydrophobic transmem-
brane domain and an intracellular domain. The alterna-
tive chTIM4 amplicons, including chTIM4L0 (2099 nt),
chTIM4L1 (1901 nt) and chTIM4L2 (1751 nt), generated
by primer pair TIM4-F1/R1, encoded open reading
frames of 612, 546 and 496 aa respectively. Moreover,
chTIM4S was amplified by a nested PCR using primer
pair TIM4-F2/R2, resulting in an 846-nt amplicon with
an encoding open reading frame of 282 aa. All the
chTIM4 gene isoforms are encoded by the same gene
(Fig. 3c). All chTIM4L isoforms contain two or three
extra exons, encoding a second IgV domain and a linker
joining it to the IgV domain that it shares with the
chTIM4 isoform. The two IgV domains are very similar,
differing in only 8 aa. The chTIM4L0 has an extended
exon 3, using a later splice donor site compared with the
chTIM4L1 isoform. Although of a similar length to exons
2 and 5, exon 3 in chTIM4L0 does not code a recogniz-
able IgV domain. The chTIM4S splices out exons 5–8,
but maintains the same exons 3 and 4 as those of the
chTIM4L1 isoform.
Tissue distribution and cellular expression of the
chTIM molecules
Expression of chTIM1 and chTIM4 in tissues and
immune cells from a line 72 SPF bird was measured by
quantitative PCR. By contrast to the rather restricted
expression of mammalian TIM1 and TIM4 (see
www.biogps.org), chTIM1 and chTIM4 were widely and
similarly expressed at the mRNA level in lymphoid and
non-lymphoid tissues (Fig. 4a). The mRNAs for the
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Figure 4. Expression patterns of mRNA of the chicken T-cell
immunoglobulin and mucin 1 (chTIM1) (blank bar) and chTIM4
(black bar), as measured by real-time RT-PCR, with results expressed
as corrected 40-Ct values  SEM, in (a) lymphoid and non-lym-
phoid chicken tissues from one bird, and (b) splenocyte subsets,
unstimulated (Un) and stimulated bone-marrow-derived antigen-
presenting cells (BM-APCs) and peripheral blood monocyte-derived
macrophages (MoMac) by lipopolysaccharide (LPS) or recombinant
chicken CD40 ligand (rchCD40L) for 24 hr, in which splenocyte
subsets and MoMac were prepared from a pooled sample of three
birds; Assays were carried out in triplicate, and the pooled data from
three experiments are shown.
Figure 5. Expression patterns of the chicken T-cell immunoglobulin and mucin 4 (chTIM4) isoforms in different strains of chicken, as measured
by RT-PCR, using primers TIM4-F1/R1. (a) Tissues from a 6-week-old line 72 male bird, (b) tissues from an age-matched J line male bird with
standard vaccination and (c) tissues from an age-matched, unvaccinated J line male bird. Lymphoid and non-lymphoid chicken tissues, where
HG refers to Harderian gland, CT, caecal tonsil, BM bone marrow, intestine, small intestine. (d) Chicken splenic cell subsets from 6-week-old
line 72 birds, including: 1, CD3
+; 2, CD4+; 3, CD8a+; 4, CD8b+; 5, Bu-1+; 6, KUL01+; 7, TCR1+ (cd T cells); 8, TCR(2 + 3)+ (abT cells). (e)
Chicken splenic cell subsets from 6-week-old J line birds: 1, CD4+; 2, CD8a+; 3, Bu-1+; 4, TCR1+; 5, TCR(2 + 3)+. M represents a DNA ladder
(bp) and the chicken GAPDH cDNA is a control. The results shown in (a), (b) and (c) are one representative of three birds and sorted cells in
(d) and (e) were pools of three birds.
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Figure 6. Characterization of anti-chicken T-cell immunoglobulin and mucin 4 (chTIM4) antibodies and chTIM4 expression in chicken antigen-
presenting cells (APCs). (a) Epitope of JH9 monoclonal antibody (mAb) was mapped to chTIM4-IgV domain by capture ELISA, whereas
chTIM4-IgV-Ig and chTIM4-mucin-Ig fusion proteins expressed by COS-7 cells were captured by anti-human IgFc antibody. (b) Immunostaining
of COS-7 cells with either mAb JH9 (anti-chTIM4) or IE12 (anti-chTIM4L1-linker), in which the cells were transfected with plasmids expressing
either full-length chTIM4 or chTIM4L1 or chTIM1. AEC substrate was used to detect bound mAbs. (c) Western blot analysis of chTIM4 protein
expression in transfected COS-7 cell lysates. (d) Flow cytometrical analysis of chTIM4 expression in bone-marrow-derived APC (BM-APC),
bone-marrow-derived macrophages (BM-Mφ) cultured from J line birds. Green, cells stained with mAb JH9; blue, cells stained with mAb IE12;
red, cells stained with KUL01 (macrophages); pink, cells stained with anti-Bu-1 (B cells); solid black, IgG2a isotype control; dotted black, IgG1
isotype control. The cells were gated on FSC and SSC plot to exclude dead cells and cell debris. Results are representative from one of three
experiments. (e) RT-PCR analysis of chTIM4 expression in BM-Mφ (1), BM-APC (2) and cultured bone marrow cells only (3) as non-treated
controls. M represents a DNA ladder (bp) and the chicken GAPDH gene is a control.
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chTIM1 and chTIM4 molecules were expressed in sple-
nic CD4+, CD8+ and TCR1+ (cd) T cells and Bu-1+ B
cells at variable levels. The chTIM mRNAs were also
expressed in unstimulated and stimulated BM-APC
(bone marrow cells cultured in the presence of rchIL-4
and rchCSF-3 for 6 days) and peripheral blood mono-
cyte-derived macrophages. Lipopolysaccharide stimula-
tion down-regulated levels of mRNA expression for
chTIM1 and chTIM4, whereas rchCD40L stimulation
had little effect (Fig. 4b).
The cellular expression pattern of chicken TIM in J line
birds was not measured. It could be different from line 72
SPF birds because the rearing conditions and genetic
background between them differ. On the other hand, as a
receptor of TIM1, TIM4 plays crucial biological activities
on TIM1-expressing cells, including cell proliferations.10
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Figure 7. (a) The ligands for chicken T-cell
immunoglobulin and mucin 1 (chTIM1) and
chTIM4 are expressed on the surface of spleno-
cytes. Splenocytes were stained with recombi-
nant fusion proteins of different domains of
chTIM1 or chTIM4. Isolated splenocytes were
stained with either human IgFc protein (grey-
filled histogram), chTIM-IgV-domain IgFc
fusion protein (dashed line), chTIM-mucin-
domain IgFc fusion protein (dotted line) or
chTIM-extracellular-domain IgFc fusion protein
(solid line). Staining was detected with a goat
anti-human-IgG-FITC polyclonal antibody. The
cells were gated on FSC and SSC plot to exclude
dead cells and cell debris. Results are representa-
tive from one of four experiments. (b) and (c)
The ligand(s) for chTIM4 are up-regulated after
stimulation, as measured by flow cytometry.
Splenocytes were cultured without or with (b)
recombinant chicken CD40 ligand (rchCD40L)
or (c) concanavalin A (ConA) for 48 hr. The
cells were co-stained with chTIM4-extracellular-
domain IgFc fusion protein conjugated to
Alexa-647, human IgFc protein as a negative
control, and either (b) anti-Bu-1-FITC or (c)
anti-CD3-FITC mAbs. Results show the whole
population of cells without any gating and are
representative from one of three experiments.
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The J line birds have multiple alternative splice TIM4 iso-
forms, therefore investigating expression pattern of its
individual isoform in tissues and immune cells would be
an urgent issue to be addressed.
Divergent expression of chTIM4 isoforms in different
strains of chicken
The expression patterns of chTIM4 isoforms were anal-
ysed by RT-PCR using TIM4-F1/R1 primers. Consistent
with quantitative PCR analysis, lymphoid and non-lym-
phoid tissues from a line 72 SPF bird predominantly
expressed the chTIM4 isoform homologous to the
mammalian gene product, whereas other isoforms were
undetectable (Fig. 5a). In contrast, in tissues from a con-
ventional J line bird with a standard vaccination schedule,
chTIM4L1 was predominantly expressed, whereas
chTIM4, chTIM4L0 and chTIM4L2 were detected in some
tissues, but at relatively low levels (Fig. 5b). To clarify if
vaccination varies the expression pattern of chTIM4 iso-
forms, tissues from a non-vaccinated J line bird were also
analysed. Again, chTIM4L1 was the predominant form,
with other chTIM4 isoforms detected at low levels
(Fig. 5c). The expression of chTIM4 isoforms in different
immune cells was also examined. The splenic cell subsets
from line 72 SPF birds consistently expressed only the
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Figure 8. Interaction of chicken T-cell immunoglobulin and mucin 1 (chTIM1) and chTIM4 with phosphatidyserine (PS) by (a) dot blot, in which
phospholipids, phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), PS and PBS as control, were dotted onto nitro-
cellulose membrane and probed by chTIM1- or chTIM4-Ig fusion protein in COS-7 supernatants, followed by anti-immunoglobulin antibody, this
experiment was repeated twice with different batch of COS-7 supernatants; and (b) solid-phase ELISA, in which phospholipids PC, PE, PI and PS,
were added to ELISA plates and air dried, and probed by purified chTIM1- or chTIM4-Ig fusion protein at different dilution in triplicate wells, fol-
lowed by anti-immunoglobulin antibody. Results are representative from one of three experiments.
Figure 9. Chicken T-cell immunoglobulin and mucin 4 (chTIM4) recognizes phosphatidylserine (PS) exposed on apoptotic splenocytes. Spleno-
cytes were cultured alone (a) or with concanavalin A (ConA) (b) or recombinant chicken CD40 ligand (rchCD40L) (c) for 48 hr. In the left-most
panels, red represents unstained cells, blue shows annexin V-FITC staining and green shows chTIM4-extracellular-domain IgFc fusion protein
staining. The cells were then stained (left column of histograms) with chTIM4-extracellular-domain IgFc fusion protein (black lines), the same
protein pre-incubated with PS for 1 hr (orange lines) or IgFc fusion protein alone as a negative control (filled histogram). Cells were also stained
similarly, but with chCTLA4-extracellular-domain IgFc fusion protein, as another negative control (right column of histograms). Binding was
detected with a rabbit-anti-human IgG-FITC polyclonal antibody. Different cell populations were gated by side and forward scatters. For each
treatment, the top panel of histograms show dead cells, the middle early apoptotic cells and the bottom panels live cells.
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chTIM4 isoform, with B cells (Bu-1+) and macrophages
(KUL01+) expressing higher levels of chTIM4 than T cells
(CD3+) and T-cell subsets, including CD4+, CD8a+,
CD8b+, TCR1+ (cd T cells) and TCR(2 + 3)+ (ab T cells)
(Fig. 5d). The immune cells isolated from vaccinated J
line birds had the same expression pattern of chTIM4 iso-
forms in T-cell subsets, including CD4+, CD8a+, TCR1+
(cd T cells) and TCR(2 + 3)+ (ab T cells), and B cells
(Bu-1+) as in the J line tissue panels; i.e. chTIM4L1 was
the predominant form (Fig. 5e).
To enable detection of the protein, monoclonal antibod-
ies (mAbs) specific for chTIM4 were produced. The mAb
JH9 was generated against the IgV domain of chTIM4
(Fig. 6a), and recognized all isoforms of chTIM4. The mAb
IE12 was raised against the linker of chTIM4L1, and conse-
quently does not cross-react with chTIM4 (Fig. 6b,c). Nei-
ther antibody cross-reacted with chTim1 (Fig. 6b,c). The
antibodies detected a 75 000 molecular weight protein for
full-length of chTIM4 and a 100 000 molecular weight pro-
tein for full-length of chTIM4L1 in transfected COS-7 cells
expressing the respective proteins (Fig. 6c). These two
mAbs were used in flow cytometry to stain BM-APC and
BM-Mφ derived from J line birds (Fig. 6d). Neither mAb
stained BM-APC, whereas both stained BM-Mφ at equal
levels. Both populations were positive for the macrophage
marker, KUL01. RT-PCR analysis confirmed that expres-
sion of chTIM4 iosforms was down-regulated in BM-APC,
but readily detected in BM-Mφ, when compared with
untreated bone marrow cells (Fig. 6e).
Ligands for chTIM1 and chTIM4
To study the ligands for chTIM1 and chTIM4, IgFc
fusion proteins for both were expressed in transfected
COS-7 cells. Attempts to express the extracellular domain
or IgV domain of chTIM4L1 were unsuccessful (see Sup-
plementary material, Fig. S1). Staining of transfected
COS-7 indicated that the fusion proteins were retained in
the endoplasmic reticulum (see Supplementary material,
Fig. S1). We speculate that the presence of two PS bind-
ing sites in the longer protein might promote retention
through binding to endoplasmic reticulum membranes.
Splenocytes were then stained with either extracellular-
domain-, IgV-domain- or mucin-domain-IgFc fusion
proteins, with human IgFc protein as a negative control
(Fig. 7a). For chTIM1, around 7% of splenocytes stained
with the extracellular-domain IgFc fusion protein. For
chTIM4, splenocytes stained strongly with the extracellu-
lar-domain-IgFc fusion protein (461% positive), weakly
with the IgV-domain-IgFc fusion protein (47% positive)
and not at all with the mucin-domain-IgFc fusion pro-
tein. Following stimulation with rchCD40L, detection of
the ligand(s) of chTIM4 on Bu-1+ splenocytes (B cells)
was increased (Fig. 7b). Similarly, stimulation of CD3+
splenocytes (T cells) with ConA increased binding activity
(Fig. 7c).
In mammals, as well as interacting with each other to
potentiate Th2 responses through APC–Th2 CD4 T-cell
interactions, TIM1 and TIM4 bind PS and mediate the
entry of enveloped viruses such as Ebola33,34 and den-
gue,35 and in PS-mediated phagocytic engulfment and
removal of apoptotic cells.1 The chTIM4 bound strongly
to PS, weakly to PE, and did not bind to PC, PI or the
negative control (PBS) in a dot blot assay (Fig. 8a). The
chTIM4-PS interaction was also confirmed in a
solid-phase ELISA in a dose-dependent manner, but the
interactions with PE were not detectable, possibly because
of the lower affinity (Fig. 8b). The chTIM1 strongly
0
20
50
40
10
60
cp
m
(×1
03
)
Treatment
anti-CD3
anti-CD28
chTim4-Ig (µg/ml) 
– + – – – – + + + +
– – + – – – + + + +
– –
1·0 2·5 5·0
– –
1·0 2·5 5.0
70
80
90
P = 0.22
P = 0.037
P = 0.045
30
Figure 10. Chicken T-cell immunoglobulin
and mucin 4 (chTIM4) is co-stimulatory for
splenocytes. Splenocytes from SPF line 72
chickens were cultured in complete RPMI-
1640 medium without or with the addition of
chTIM4-extracellular-domain IgFc fusion pro-
tein (chTIM4-Ig) for 48 hr in wells pre-coated
without or with anti-chicken CD3 or/and
CD28 antibodies. Error bars represent
mean  SEM of triplicate wells for each treat-
ment. The pooled results from four experi-
ments are shown and the P value was
calculated using Student’s t-test when com-
pared with the cells stimulated only by CD3
and CD28 antibodies.
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bound to PS but not to other phospholipids in both
assays (Fig. 8a,b). We then tested the ability of chTIM4
to recognize dying cells. Splenocytes were cultured alone
(Fig. 9a) or with ConA (Fig. 9b) or rchCD40L (Fig. 9c)
for 48 hr. In all three cell populations, live cells were
unstained, but dying (early apoptotic) and dead cells
stained progressively more strongly with chTIM4. This
staining was largely ablated following pre-incubation of
chTIM4 with PS.
ChTIM4 is co-stimulatory for chicken splenocytes
Based upon the known co-stimulatory activity of TIM
protein in mammals, we tested the ability of chTIM4-
extracellular-domain-IgFc fusion protein to increase the
response of chicken cells to sub-optimal concentrations of
anti-chicken CD3 and CD28 mAbs for 48 hr. The
chTIM4 produced a clear dose-dependent co-stimulation
of thymidine incorporation in the chicken splenocytes
(Fig. 10).
Discussion
We identified the chicken TIM molecules based on well-
studied mammalian TIMs. The murine TIM family was
originally located within an airway hyper-reactivity regu-
latory locus on chromosome 11,31 syntenic to human
chromosomal region 5q23-35, which contains the human
TIM family genes. Both regions are linked to atopy and
asthma.36–38 The human 5q region contains a large num-
ber of cytokine genes, including IL-9, IL-12 p40 and the
Th2 cytokine cluster, which contains the genes that
encode IL-4, IL-5 and IL-13, as well as GM-CSF and IL-
3.36,39 Chromosome 13, where the TIM genes are located,
appears to be the syntenic chicken chromosome, and
encodes IL-9, IL-12 p40, the Th2 cytokine cluster (IL-4,
IL-5 and IL-13), GM-CSF and IL-3.18,40–42 Like mammals,
TIM families in avian species seem to be diverse, with
TIM1, TIM3 and TIM4 in a wild bird (zebrafinch) but
only TIM1 and TIM4 in the domestic birds (turkey and
chicken). Chromosome 13 regions have been linked to
genetic control of innate and acquired immunity in layer
birds.43 It would be of some interest to determine if there
is within-species variation in TIM1 and TIM4 expression
levels that could contribute to immune phenotypes.
Murine and human TIM1 and TIM4 are immune-
related molecules, most highly expressed at the mRNA
level in immune cells and lymphoid organs4,44–46
(www.biogps.org), but with no detectable expression in
non-lymphoid tissues, except for high TIM1 expression in
the kidney.2 By contrast, the chicken TIM1 and TIM4
mRNAs were highly expressed in the immune and non-
immune tissues tested. The difference may be partly
explained by the fact that the chicken immune system
does not have lymph nodes. Instead, the chicken develops
diffuse lymphoid aggregates in organs.47 Within leucocyte
populations, the expression of chTIM1 and chTIM4
resembles mammalian patterns, including significant T-
cell expression. Notably, chTCR1+ cells, which are cd T
cells, also highly expressed chTIMs. The biological func-
tion of these cells is unclear, but they are clearly capable
of cytotoxic activity in vitro.48
The data from mouse suggest that TIM1–TIM4 interac-
tion promotes T-cell activation,10 and that both can bind
PS and contribute to clearance of apoptotic cells.9 We
demonstrated that chTIM4 fusion protein bound to dying
cells, and that binding was also increased upon activation
of target cells (Fig. 9). Activation stimuli can also induce
PS exposure on different immune cells and strongly
depends on the amount of presented antigens.49,50 The
binding was abolished by pre-incubation of the protein
with PS. Crystallographic analysis of mammalian TIM4
revealed that PS penetrated into a metal-ion-dependent
ligand binding site in the TIM4-IgV domain and co-ordi-
nated with the metal ion.30 The PS binding domain is
conserved in the chicken protein. TIM4 bound to PS
mediated uptake of apoptotic cells and mutations in the
metal-ion-dependent ligand binding site eliminated PS
binding and phagocytosis.9 However, TIM4 has no signal
transduction motif in its cytoplasm domain. Therefore, it
is not able to initiate particle uptake, but rather tethers
the apoptotic debris allowing cooperation with other
receptors to mediate internalization.51
Administration of murine TIM4-Ig fusion protein
in vivo with antigen produces increased basal T-cell pro-
liferation and enhanced production of IL-2 and inter-
feron-c.10 In vitro studies have produced contrasting
conclusions. In the presence of anti-CD3 and anti-CD28
antibodies for pre-activation of naive T cells, TIM4-Ig
induced dramatically higher levels of proliferation and
cytokine production than those stimulated with a control
protein, as well as an increased phosphorylation of TIM1.
TIM4 was therefore defined as a co-stimulatory molecule
that promotes T-cell expansion and survival by cross-
linking TIM1 on activated T cells.10,11 By contrast, mur-
ine TIM4-Ig inhibited the proliferation of naive T cells,
on which there is very low or no TIM1 expression, possi-
bly by binding to an unknown ligand.12 The chicken
TIM4-Ig fusion protein induced splenocyte proliferation
in the presence of anti-chicken CD3 and CD28 antibod-
ies. Although it is not determined which T-cell subset(s)
proliferated, this result suggests that the chicken TIM4
molecule has a function in the regulation of T-cell
immune responses.
In summary, the chicken has fewer TIM family mem-
bers than mammals, but the functions of the chicken
members appear conserved. Uniquely, alternative splicing
of chTIM4 generates multiple transcripts which show
some preferential expression in different strains of
chicken. The chicken lacks many important components
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of mammalian Th2-associated responses and Th2-asso-
ciated allergy is rarely seen in chickens. It remains to be
determined whether chTIM1 and chTIM4 contribute to
the regulation of avian cell-mediated immunity in vivo.
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